Redefining Medical Education

Malvern, PA
Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer? This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.
1
273
Replying to @HadidiSamer
Strange to have approval before publication. Hope we will have a publication ASAP.
1
4
9
1,775
Free @RedMedEd CE opportunity! How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer? Learn from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
1
2
1
319
APPs: level up your bladder cancer management game . Test your knowledge of treatment approaches in our game show–style CE activity. Rack up points, earn credit, and sharpen your management skills! With @BladderCancerUS and Colleen Tetzlaff @Onc_PA_Mom
1
1
39
Clinical Callout, our CME-accredited activity on developments in bladder cancer patient care, provides downloadable practice tools—including several developed by our partner @BladderCancerUS —to help you optimize care for your bladder cancer patients.
1
1
490
CME/CE roundtable: muscle-invasive bladder cancer care. Review important developments in treatment with @BladderCancerUS, @ERPlimackMD, @siadaneshmand, and Colleen Tetzlaff @Onc_PA_Mom
1
510
Presented by lymphoma experts and featuring patient cases, @lymphoma Lymphoma Rounds Symposium series provides information on new therapies and strategies for lymphoma care. Each activity in this series explores an issue central to lymphoma management.
1
58
Click on the link below to view catalog and earn CME education.redmeded.com/s/cat…
27
Quick, case-based myeloma CME—available now. Make sure your approach to relapsed myeloma is keeping pace with recent advances in our newest Ace the Case activities with @SurbhiSidanaMD #mmsm
1
64
How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer? Continuing education from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care. @RedMedEd
1
2
3
649
⚠️ CDC estimates that nearly 500,000 American suffer from Alpha-gal syndrome, with emerging evidence suggesting that number is potentially in the millions. “We intend to bring the same urgency, innovation, and scientific rigor to Alpha-gal syndrome that we are to Lyme disease.” —@SecKennedy
139
272
1,178
123,488
RedMedEd retweeted
Replying to @VincentRK
This is what happens with the work all the folks here have done
2
15
49
17,945
Think you’re up to date on the AEs associated with bladder cancer immunotherapy? Find out in this game-based CME activity developed for APPs, nurses, and other HCPs who treat bladder cancer. @RedMedEd
1
1
241
31% of patients needed to travel by air to be diagnosed with amyloid. ⁦@SLentzsch⁩ sharing key lessons for all doctors to have their clinical hats on to avoid missing this diagnosis ! #mmsm
3
12
53
3,100
Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer? This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.
1
1
2
316
Replying to @RedMedEd
1
122